Carvedilol

卡维地洛

Report date: 2026/05/13 20:02:10

Base Information

Drug NameCarvedilol
Drug Alias Name卡维地罗KarvediloliCarvedilolumKarvedilolKarvedilolis +[20] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockersBeta adrenergic receptors antagonistsAdrenergic receptor alpha-1 antagonists
TargetsVoltage-gated calcium channelBeta adrenergic receptorsAdrenergic receptors alpha-1
Therapy Area/IndicationsSleepAnxietySubstance-Related Disorders +[22] 
Global Approved IndicationsHypertensionAngina PectorisHeart Failure +[4] 
Approved Indications in ChinaHypertensionHeart Failure
Original Approved Country/TerritoryBelgium
Original Approved Date1990/01/01
Country/TerritoryBelgiumCanadaUnited States +[9] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesHôpitaux Universitaires de StrasbourgWaylis Therapeutics LLCMiami Heart Research Institute +[8] 
Inactive CompaniesCenter For Translational Neuroscience, University Of Copenhagen, DenmarkActavis IncUniversity Of Minnesota +[6] 
Active IndicationsDrug-Related Side Effects and Adverse ReactionsHypertensionVentricular Dysfunction, Left +[11] 
Inactive IndicationsSleepAnxietySubstance-Related Disorders +[11] 

Other Information

ATC CodeC07AG02
Related LinksWikipediaDrugBankKEGG